Zaltrap
Zaltrap
Zaltrap (pronounced: zăl-trăp), also known as Aflibercept, is a biopharmaceutical drug used in the treatment of metastatic colorectal cancer. It is a fusion protein designed to inhibit the blood supply to tumors.
Pronunciation
Zaltrap is pronounced as "zăl-trăp".
Etymology
The name Zaltrap is a brand name, and its etymology is not publicly disclosed. However, it is known that the generic name, Aflibercept, is derived from the terms "Vascular Endothelial Growth Factor" (VEGF) and "receptor" (R), indicating its function as a VEGF receptor.
Function
Zaltrap works by blocking the action of a certain natural substance that helps cancer cells grow and divide. This helps to slow or stop the growth of cancer cells and may help shrink tumors.
Related Terms
Usage
Zaltrap is used in combination with other medications to treat certain types of colorectal cancer. It is given by injection into a vein by a healthcare professional.
Side Effects
Common side effects of Zaltrap include fatigue, diarrhea, decreased appetite, high blood pressure, weight loss, and changes in voice. Serious side effects can include severe bleeding, wound healing complications, and gastrointestinal perforation.
See Also
External links
- Medical encyclopedia article on Zaltrap
- Wikipedia's article - Zaltrap
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski